Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118407) titled 'Prediction of Bone Tumor Risk and Treatment Prognosis Based on Artificial Intelligence and Multimodal Imaging' on Feb. 5.
Study Type: Diagnostic test
Study Design:
Cross-sectional
Primary Sponsor: Shanghai Tenth People's Hospital
Condition:
bone tumor
Intervention:
Gold Standard:Pathological examination
Recruitment Status: Not Recruiting
Phase: Diagnostic New Technique Clincal Study
Date of First Enrollment: 2026-02-15
Target Sample Size: Target condition:300;Difficult condition:50
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=303419
Disclaimer:...